title: Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas.
abstract: Human serum alpha-fetoprotein (AFP) is elevated in not only hepatocellular carcinoma (HCC) but also benign liver diseases. AFP produced in HCC and benign liver diseases was separated into several isoforms corresponding to different sugar chain structures by several types of lectin affinity electrophoresis, and the HCC-specific AFP isoform was discriminated from those of benign liver diseases. Because a small amount of HCC-specific AFP isoform was detected in cord serum AFP, the whole sugar chain structures of human cord serum AFP were determined, as follows: Neu5Ac alpha 2-->Gal beta 1-->4GlcNAc beta 1-->2Man alpha 1-->6(Neu5Ac alpha 2 -->6Gal beta 1-->4GlcNAc beta 1-->2Man alpha 1-->3)Man beta 1-->4R1 and R2, Gal beta 1-->4GlcNAc beta 1-->2Man alpha 1-->6(Neu5Ac alpha 2-->6Gal beta 1 -->4GlcNAc beta 1-->2Man alpha 1-->3)Man beta 1-->4R1 and R2, and Neu5Ac alpha 2-->3Gal beta 1-->4GlcNAc beta 1-->2Man alpha 1-->6(Neu5Ac alpha 2 -->6Gal beta 1-->4GlcNAc beta 1-->2Man alpha 1-->3)Man beta 1-->4R1 and R2 in the ratio of 81.6:8.9:9.5. R1 and R2 denote GlcNAc beta 1-->4GlcNAcOT (subscript OT represents an NaB3H4-reduced oligosaccharide) and GlcNAc beta 1-->4(Fuc alpha 1-->6)GlcNAcOT, respectively, and the ratio between R1 and R2 in the respective fractions was approximately 19:1. In contrast, the sugar chain structure of HCC highly specific AFP isoform was found to comprise a monosialyl-biantennary sugar chain with additional fucosylation of the proximal N-acetylglucosamine. Fucosylation of AFP produced in fetal liver increased in inverse proportion to the gestation period, in weeks, indicating that fucosylation of AFP in HCC may be related to the dedifferentiation of human hepatocytes through malignant transformation.
authors.affiliation: Department of Biochemistry, Sasaki Institute, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Yamashita
authors.forename: K
authors.initials: K
authors.lastname: Taketa
authors.forename: S
authors.initials: S
authors.lastname: Nishi
authors.forename: K
authors.initials: K
authors.lastname: Fukushima
authors.forename: T
authors.initials: T
authors.lastname: Ohkura
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D002240:Carbohydrate Sequence; D006528:Carcinoma, Hepatocellular / Q000097:blood* / Q000737:chemistry / Q000378:metabolism; D002846:Chromatography, Affinity; D004590:Electrophoresis, Paper; D005312:Fetal Blood / Q000737:chemistry*; D006023:Glycoproteins / Q000096:biosynthesis / Q000097:blood / Q000737:chemistry*; D006801:Humans; D037102:Lectins; D008099:Liver / Q000196:embryology / Q000378:metabolism*; D008107:Liver Diseases / Q000097:blood / Q000378:metabolism; D008113:Liver Neoplasms / Q000097:blood* / Q000737:chemistry / Q000378:metabolism; D008969:Molecular Sequence Data; D009844:Oligosaccharides / Q000096:biosynthesis / Q000097:blood / Q000737:chemistry*; D010835:Phytohemagglutinins; D012680:Sensitivity and Specificity; D000509:alpha-Fetoproteins / Q000096:biosynthesis* / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D006023:Glycoproteins; D037102:Lectins; D009844:Oligosaccharides; D010835:Phytohemagglutinins; D000509:alpha-Fetoproteins